2009
DOI: 10.1016/j.peptides.2009.05.011
|View full text |Cite
|
Sign up to set email alerts
|

Bioavailability of β-amino acid and C-terminally derived PK/PBAN analogs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
6
1

Year Published

2009
2009
2019
2019

Publication Types

Select...
5
3

Relationship

2
6

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 40 publications
0
6
1
Order By: Relevance
“…The structure and pheromone activity of PBAN of Helicoverpa zea was identified by Rain et al (1989) and subsequently the PBAN sequence of H. zea (34 amino acids), particularly the terminal sequence (24 -33) was synthesized to identify the pyrokinin/PBAN bioactivity of other insects. The neuropeptide activity was studied by injecting the synthetic peptide into the brain of insects or used as an antibody in ELISA (Jurenka et al, 1995;Altstein et al, 1999;Rain et al, 2003, Hariton et al, 2009. In the present study, we could not find the immunoreactivity of PBAN-like peptide in the head of another psocid L. bostrychophia female.…”
Section: Discussioncontrasting
confidence: 62%
“…The structure and pheromone activity of PBAN of Helicoverpa zea was identified by Rain et al (1989) and subsequently the PBAN sequence of H. zea (34 amino acids), particularly the terminal sequence (24 -33) was synthesized to identify the pyrokinin/PBAN bioactivity of other insects. The neuropeptide activity was studied by injecting the synthetic peptide into the brain of insects or used as an antibody in ELISA (Jurenka et al, 1995;Altstein et al, 1999;Rain et al, 2003, Hariton et al, 2009. In the present study, we could not find the immunoreactivity of PBAN-like peptide in the head of another psocid L. bostrychophia female.…”
Section: Discussioncontrasting
confidence: 62%
“…Increased knowledge on neuropeptide actions, and their associated regulatory roles, may reveal suitable targets for design of environmentally benign control compounds to eradicate and/or control these medically relevant pest species (Scherkenbeck and Zdobinsky, 2009). Development of peptidomimetics, which are synthetic analogs that can match or exceed activity of the native peptides and can have increased biostability (Hariton et al, 2009;Zubrzak et al, 2007), is increasingly needed as the protozoan parasites develop resistance to the front line drugs used to treat Chagas' disease (Wilkinson et al, 2008).…”
Section: Introductionmentioning
confidence: 99%
“…Recently, we demonstrated, for the first time, that native, unmodified linear peptides of various lengths belonging to the PK/PBAN family (PBAN, leucopyrokinin, pheromonotropin and myotropin), as well as small, linear synthetic β‐substituted peptides (Ac‐YFT[β 3 P]RLa, Ac‐Y[β 2 homoF]TPRLa, Ac‐Y[β 3 F]TPRLa and Ac‐[β 3 F]FT[β 3 P]RLa) and two analogs (YFTPRLa and the acylated peptide Ac‐YFTPRLa) were highly bioavailable, i.e. they could penetrate the cuticle very efficiently and reach and activate their target organ following topical application to the female moth abdomen, at a dose of 1 nmol in either double‐distilled water (DDW) or dimethylsulfoxide [19,20].…”
Section: Introductionmentioning
confidence: 99%
“…and two analogs (YFTPRLa and the acylated peptide Ac-YFTPRLa) were highly bioavailable, i.e. they could penetrate the cuticle very efficiently and reach and activate their target organ following topical application to the female moth abdomen, at a dose of 1 nmol in either double-distilled water (DDW) or dimethylsulfoxide [19,20].…”
Section: Introductionmentioning
confidence: 99%